A test of the relative merits of timed melatonin for the treatment of cardiac ischemia as well as hypertension refractory to other drugs is documented against the background of earlier chronobiological studies on blood pressure (BP), disease risks, circadian hyper-amplitude-tension and melatonin effects broadly.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0753-3322(04)80021-0 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!